Marten Beeg

Mario Negri Institute for Pharmacological Research — Italy

Medicine · Health Sciences

26h-index2.6kcitations67works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(33), Prion Diseases and Protein Misfolding(10), Computational Drug Discovery Methods(8), Monoclonal and Polyclonal Antibodies Research(7), Cholinesterase and Neurodegenerative Diseases(7)

Publications66 total

Disrupting the ERO1α–PDIA1 Interaction with AI-Engineered Minibinders: A Novel Dual-Mechanism Therapy for Breast Cancer
Free Radical Biology and Medicine·2025
Tau catalyzes amyloid-β aggregation in a fold-dependent manner
2025Open Access
Integrating Surface Plasmon Resonance and Docking Analysis for Mechanistic Insights of Tryptase Inhibitors
Molecules·2025Open Access
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
Cell Death and Disease·2025· 10 citedOpen Access
Tau oligomers impair memory and synaptic plasticity through the cellular prion protein
Acta Neuropathologica Communications·2025· 8 citedOpen Access
The Detection of Toxic Amyloid-β Fibril Fragments Through a Surface Plasmon Resonance Immunoassay
International Journal of Molecular Sciences·2024· 2 citedOpen Access
The cellular prion protein mediates Tau oligomer‐induced memory impairment in mice
Alzheimer s & Dementia·2024Open Access
Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors
International Journal of Molecular Sciences·2024· 17 citedOpen Access
Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1
Antibodies·2024· 1 citedOpen Access
PB0667 Development and Clinical Utility of Anti-Emicizumab Antibody Detection Assays
Research and Practice in Thrombosis and Haemostasis·2023· 2 citedOpen Access
Anti-emicizumab antibodies do not cross-react with mim8 in vitro
Research and Practice in Thrombosis and Haemostasis·2023· 5 citedOpen Access
A Comprehensive Technology Platform for the Rapid Discovery of Peptide Inhibitors against SARS-CoV-2 Pseudovirus Infection
International Journal of Molecular Sciences·2023· 4 citedOpen Access
Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury
Molecular Psychiatry·2023· 16 citedOpen Access
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity
Annals of Medicine·2023· 2 citedOpen Access
Rational Design of a Peptidomimetic Inhibitor of Gelsolin Amyloid Aggregation
International Journal of Molecular Sciences·2022· 9 citedOpen Access
Rational Design of a Peptidomimetic Inhibitor of Gelsolin Amyloid Aggregation
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants
Cell Death and Disease·2022· 20 citedOpen Access
New nanostructures inhibiting human mannose binding lectin identified by a novel surface plasmon resonance assay
Sensors and Actuators B Chemical·2022· 3 citedOpen Access
A novel hotspot of gelsolin instability triggers an alternative mechanism of amyloid aggregation
Zenodo (CERN European Organization for Nuclear Research)·2021Open Access
A novel hotspot of gelsolin instability and aggregation propensity triggers a new mechanism of amyloidosis
arXiv (Cornell University)·2021Open Access
page 1 of 4Next →

Frequent Co-authors

Marco Gobbi(42), Mario Salmona(32), Luisa Diomede(15), Matteo Stravalaci(10), Laura Colombo(10), Gianluigi Forloni(8), Fabrizio Tagliavini(8), Alfredo Cagnotto(8), Claudia Balducci(7), Antonio Bastone(6), Fabio Fiordaliso(6), Roberto Chiesa(5), Michela Morbin(5), Alessandro Corbelli(5), Arianna Piotti(5), Ada De Luigi(5), Emiliano Biasini(4), Claudia Manzoni(4), Giuseppe Di Fede(4), Giacomina Rossi(4)